Aytu BioScience (AYTU) Tops Q1 EPS by 65c

Aytu BioScience (NASDAQ: AYTU) reported Q1 EPS of $0.65. Revenue for the quarter came in at $18.5 million.

For earnings history and earnings-related data on Aytu BioScience (AYTU) click here.

You May Also Be Interested In

• KeyBanc Downgrades Primoris Services Corporation (PRIM) to Sector Weight
• Microsoft (MSFT) Reiterated at Market Outperform by Citizens as Cowork Rollout Announced
• Texas Capital Securities Downgrades Arcosa (ACA) to Hold